News and research before you hear about it on CNBC and others. Claim your one week free trial for StreetInsider Premium here.
INFORMATION REQUIRED IN THE PROXY CIRCULAR
INFORMATION ON ANNEX 14A
PROXY STATEMENT UNDER SECTION 14(A) SECURITIES
EXCHANGE ACT 1934 (AMENDMENT NO. ____)
Filed by declarant [X]
Filed by a Party other than the [_]
Check the appropriate box:
[_] Preliminary Proxy Statement
[_] Confidential, for the exclusive use of the Commission (as permitted by rule 14a-6(e)(2))
[_] Definitive Power of Attorney Statement
[X] Final additional materials
[_] Solicit Materials under Rule 14a-12
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.
BNY Mellon High Yield Strategies Fund
(Name of holder as specified in its charter)
(Name of person(s) filing proxy statement, if other than holder)
Payment of application fees (check the appropriate box):
[X] No fees required.
[_] Fees calculated in the table below in accordance with Rules 14a-6(i)(1) and 0-11 of the Exchange Act.
(1) Title of each category of securities to which the transaction applies:
(2) Total number of securities to which the transaction applies:
(3) Unit price or other underlying value of the transaction calculated in accordance with Rule 0-11 of the Exchange Act:
(4) Proposed maximum aggregate value of the transaction:
(5) Total fees paid:
[_] Expenses previously paid with preliminary materials.
|[_]||Check the box if a portion of the fee is offset pursuant to Rule 0-11(a)(2) of the Exchange Act and identify the deposit for which the offset fee was previously paid.|
Identify the previous filing by the registration statement number, or the form or schedule and the date it was filed.
(1) Amount already paid:
(2) Registration Form, Schedule or Declaration No:
(4) Filing date:
BNY MELLON HIGH YIELD STRATEGIES FUND
BNY MELLON ALCENTRA GLOBAL CREDIT INCOME 2024 TARGET TERM FUND, INC.
BNY MELLON ALCENTRA GLOBAL MULTI-STRATEGY CREDIT FUND, INC.
c/o BNY Mellon Investment Adviser, Inc.
As we recently informed you in separate proxy documents, a special joint meeting of shareholders (the “Special Meeting”) of BNY Mellon High Yield Strategies Fund (the “High Yield Strategies Fund”), BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (the “Target Term Fund”) and BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (the “Multi-Strategy Fund” and collectively with the High Performance and Target Futures Fund, the “Funds”) has been convened to ask the shareholders of each Sub-Fund to consider approving a new outsourced investment advisory agreement between Alcentra NY, LLC (“Alcentra NY “) and the Fund’s investment adviser, BNY Mellon Investment Adviser, Inc. (“BNYM Adviser”), on behalf of the Fund (the “New Sub-Advisor Agreement”).
Currently, the portfolio managers of the High Yield Strategies Fund are both employees of BNYM Adviser and Alcentra NY and manage the High Yield Strategies Fund as employees of BNYM Adviser. Alcentra NY currently acts as investment sub-advisor to the Target Term Fund and the Multi-Strategy Fund, pursuant to an advisory sub-adviser agreement between the adviser BNYM, in respect of each Fund, and Alcentra NY ( the “Current Accord Sub-Adviser”). Alcentra NY is currently a subsidiary of BNYM Adviser and a subsidiary of Alcentra Group Holdings, Inc., which is currently an indirect wholly-owned subsidiary of The Bank of New York Mellon Corporation (” BNY Mellon”), the parent company of BNYM Advisor. In May 2022, BNY Mellon entered into a definitive agreement with Franklin Resources, Inc., a global investment management organization operating as Franklin Templeton, pursuant to which Franklin Templeton , subject to certain regulatory approvals and the satisfaction of other conditions, will acquire Alcentra Group Holdings , Inc., and its subsidiaries, including Alcentra NY (the “Transaction”). Alcentra NY will become a subsidiary of Franklin Templeton and the portfolio managers of the High Yield Strategies Fund will cease to be employees of BNYM Adviser and will be employees of Alcentra NY only. The transaction will also result in a “change of control” of Alcentra NY, which will result in an automatic assignment and termination of the current sub-advisory agreement for each of the Target Futures Funds and the Multi-Strategy Fund. The Transaction is expected to close in the fourth quarter of 2022 or the first quarter of 2023 (the “Closing Date”). of Alcentra NY, and Alcentra NY to continue to provide sub-investment advisory services to the Target Term Fund and the Multi-Strategy Fund, in each case from the closing date of the transaction, when Alcentra NY becomes a subsidiary of Franklin Templeton, BNYM’s adviser has recommended, and each fund’s board has approved, the new sub-advisor agreement between BNYM’s adviser, as it relates to the fund, and Alcentra NY.
The new sub-advisor agreement must be approved by the shareholders of each Fund before it can become effective. Accordingly, the Board has convened the Special Meeting to obtain shareholder approval of the new Sub-Advisor Agreement for each fund to ensure the continuity of fund portfolio management after the closing date of the operation.
The investment objective, strategies and policies of each Fund will not change as part of the implementation of the new sub-advisory agreement. There will be no increase in the advisory fee payable by a Fund to the BNYM advisor as a result of the Transaction. The sub-advisory fees payable to Alcentra NY under the new sub-advisory agreement will be payable by BNYM’s adviser and not by the Fund. The sub-adviser fees payable by BNYM Adviser to Alcentra NY under the new sub-advisory agreement will be the same as those currently payable to Alcentra NY under the respective current sub-advisory agreement for the target futures fund. and the multi-strategy fund.
The Special Meeting will be held on October 13, 2022 at 10:00 a.m. Eastern Time and will be held as a virtual meeting only. To participate, please see the instructions on the joint proxy statement mailed to you.
WHAT DO WE NEED FROM YOU?
In order to ensure that Alcentra NY can provide uninterrupted portfolio management services for the Funds after the closing date of the transaction, the shareholders of each Fund must approve the new sub-advisor agreement for each Fund upon the special assembly. Please also note that each Fund’s shareholder base is made up of thousands of investors like you, making your vote even more important, regardless of how many shares you hold. Therefore, your vote is essential to the approval of this proposal..
For more information on the special meeting, the proposal and how to vote or to obtain a copy of the joint proxy statement, you can go to https://im.bnymellon.com/us/en/individual/resources /proxy-materials.jsp. or contact us at 877-361-7968 between 9:00 a.m. and 10:00 p.m. EST, Monday through Friday and 10:00 a.m. to 6:00 p.m. EST on Saturday.
We greatly appreciate your consideration and investment in the BNY Mellon family of funds.
/s/ David Di Petrillo
BNY Mellon Family of Funds